They're complementary
A 2023 observational review noted some centers explore dual therapy in selected, closely monitored patients with severe obesity and metabolic dysfunction
I recommend fiber as part of a balanced diet
The cost barrier is equally structural: at USD 1,000-1,300 per month without insurance, GLP-1 drugs are affordable only to a small fraction of the global population who could benefit clinically, concentrating commercial market growth in the wealthy minority of the total addressable patient population
While not an overnight fix, consistent useespecially under professional supervisioncan produce beautiful results with minimal risk
Wang J, Zhao D, Ding CZ, Guo F, Wu LN, Huang FJ, et al